Please login to the form below

Not currently logged in
Email:
Password:

Publicis Healthcare Group appoints new chief financial officer

Nathalie Le Bos was previously the group’s Europe CFO

Publicis_Nathalie_Le_Bos

New York-headquartered Publicis Healthcare Communications Group (PHCG) has named Nathalie Le Bos as the group's new chief financial officer (CFO).

She takes over the role previously held by Ann Garreaud, who recently took up the position of global CFO for Publicis Worldwide in Paris.

In her new role, Le Bos will focus on strengthening the financial functions of the Publicis Groupe network, which manages healthcare brands including Digitas Health, Saatchi & Saatchi Health and Razorfish Healthware.

Previously based in Paris, Le Bos has seven years' experience working with the Publicis Groupe, most recently as CFO, Europe for PHCG. She also served as operations control director for Publicis Worldwide.

Prior to joining Publicis, she was worked for Omnicom Group at Tequila as CFO and for Havas Group in various roles.

“Nathalie was an outstanding CFO for our European operations during a challenging economy,” said Nick Colucci, president and CEO of PHCG.

“I am fortunate to have her join my executive leadership team at the PHCG global headquarters. Her unique perspective and experience will prove invaluable as we continue to increase profitability and efficiencies for our clients across the globe."

Commenting on her appointment, Le Bos said: "PHCG continues to transform itself to ensure we offer the very best to our global clients.  

“I look forward to working closely with Nick and the rest of the leadership team to continue PHCG's strong financial performance."

21st January 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS Just::

HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics